MedTrace Logo

Comorbidities and Healthcare Utilisation: Indicators for Improving COPD Diagnosis

NCT01655667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38859

Last updated 2012-08-02

No results posted yet for this study

Summary

To characterise and understand the current UK COPD population including demographics, active comorbidities and missed opportunities for COPD diagnosis in the years previous to diagnosis

Conditions

Sponsors & Collaborators

  • Department of Health, United Kingdom

    collaborator OTHER_GOV

  • Research in Real-Life Ltd

    lead NETWORK

Principal Investigators

  • David B Price, MD · Research in Real-Life Ltd

  • Dermot Ryan, MBBS · University of Edinburgh

  • Rupert Jones, MBBS · Peninsula College of Medinicne and Dentistry

  • Eric Bateman, MD · University of Cape Town

  • Matt Kearney, MPH · Department of Health, United Kingdom

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-02-28
Completion
2012-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655667 on ClinicalTrials.gov